About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...

Digital GMP expectations are increasing, driven by Annex 11 and Annex 22, necessitating robust lifecycle management, data ...

G-protein coupled receptors (GPCRs) are proteins triggered by ligands (protein-binding chemicals) from outside cells to ...

Pluri (PLUR) announced expansion of its manufacturing agreement signed in 2024 with Remedy Cell. Under the ongoing collaboration Remedy Cell’s ...

Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...

See how BioDlink’s digital-intelligence platform is driving three major improvements in lyophilization workflows.

KSH International is selling its shares in the price band of Rs 365-384, applied for a minimum of 39 shares and its multiples ...

Hamilton today announced the launch of GlucoSense, a breakthrough in bioprocess analytics that introduces the first reusable, in situ glucose sensor designed to deliver continuous, real-time ...

Abstract: The Industry 5.0 revolution has launched a new age of intelligent manufacturing equipment, which is crucial to our society and economy. Industry 5.0 aims to enhance human potential by ...

Contract Pharma has long chronicled the evolution of the CDMO, as seen in pieces like The Modern CDMO and CDMOs: The Cornerstone of Biopharmaceutical Innovation, yet once again the goalposts have ...

Abstract: The complexity of modern system and manufacturing process development often leads to inefficiencies in responsiveness, cost, and quality. This article presents a comprehensive methodology ...